Celltrion to Conduct Trial of Remsima as COVID-19 Therapeutics in UK
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
158 total views, 3 views today
146 total views, 3 views today
141 total views, 6 views today
438 total views, 15 views today
126 total views, 2 views today
130 total views, 3 views today
155 total views, 2 views today
51 total views, 5 views today
96 total views, 2 views today
122 total views, 2 views today
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |